Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Ramirent in connection with its acquisition of JIAB
Mandate

Vinge advises Ramirent in connection with its acquisition of JIAB

March 21, 2023 Banking and Finance M&A Corporate Commercial IT, Telecommunications and Outsourcing Intellectual Property Real Estate and Construction

Vinge advises Ramirent AB in connection with its acquisition of JIAB Hyrcenter (consisting of the companies JIAB Hyrcenter AB and JIAB Boden AB). Ramirent thereby further strengthens its position in Norrbotten and as the largest machine rental company in Sweden.

Vinge’s team mainly consist of Jonas Johansson, Per Kling, Elsie Nassar and Nando Basic (M&A), Arvid Axelryd and Emma Gustavsson (IPR), Seyran Sahin and Ida Redander (Banking and finance), Anna Ståhlklo, Anna Högsten and Maja Eliasson (Employment), Martin Boström and Mario Saad (Corporate commercial), Karolina Fuhrman and Elis Allmark (IT & GDPR), Tove Tullberg and Julia Löfqvist (compliance), Rebecka Maltenius (real estate), and Emy Rydén and Ellinore Boström Andersson (project assistants).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026